{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:34Z","timestamp":1787008774823,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Attention-deficit\/hyperactivity disorder (ADHD) is increasingly diagnosed in adults and is associated with cardiometabolic diseases. Yet, the associations between ADHD and cardiometabolic risk profile, participation in non-pharmacological interventions, and long-term outcomes in patients with myocardial infarction (MI) remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This observational study involved patients from the SWEDEHEART (the Swedish Web-system for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapy) registry, aged 18\u201374 years old, diagnosed with their first acute MI from 2006 to 2020. We assessed the associations between ADHD and cardiometabolic risk profile (clinical parameters, disease histories, and behavioural factors), engagement in guideline-recommended non-pharmacological interventions, recurrent cardiovascular events, and mortality. We analysed adults with MI with ADHD (n = 582) and without ADHD (n = 2704). Most clinical parameters and disease histories did not differ significantly between groups. However, patients with ADHD had higher risks of smoking (risk ratio, RR = 1.53; 95% confidence interval 1.36\u20131.71] and snus use (RR = 1.65; 1.36\u20131.99), were less likely to participate in follow-up evaluations (RR = 0.87; 0.79\u20130.96), or to stop smoking after MI (RR = 0.76; 0.63\u20130.91). They had a higher rate of all-cause mortality (hazard ratio = 2.02; 1.05\u20133.88) after discharge, but not recurrent cardiovascular events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adults with MI and ADHD present similar cardiometabolic risk profiles but poorer lifestyle behaviours, lower engagement in recommended interventions, and higher mortality compared with those without ADHD, underscoring the need for integrated cardiology care with psychiatric services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf151","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T19:33:44Z","timestamp":1744054424000},"source":"Crossref","is-referenced-by-count":4,"title":["Attention-deficit\/hyperactivity disorder and cardiometabolic risk profile in patients with acute myocardial infarction: data from the SWEDEHEART registry"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-2301","authenticated-orcid":false,"given":"Honghui","family":"Yao","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Brikell","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Global Public Health and Primary Care, University of Bergen , Bergen ,","place":["Norway"]},{"name":"Department of Biomedicine, Aarhus University , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Larsson","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, \u00d6rebro University , \u00d6rebro ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Du Rietz","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina A","family":"Hartman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, University of Groningen , Groningen ,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-1379","authenticated-orcid":false,"given":"Pontus","family":"Andell","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Karolinska Institutet, and ME Cardiology, Heart, Vascular and Neuro Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-1417","authenticated-orcid":false,"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2025041115513250700_zwaf151-B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","article-title":"Attention-deficit\/hyperactivity disorder","volume":"10","author":"Faraone","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2025041115513250700_zwaf151-B2","doi-asserted-by":"crossref","first-page":"04009","DOI":"10.7189\/jogh.11.04009","article-title":"The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis","volume":"11","author":"Song","year":"2021","journal-title":"J Glob Health"},{"key":"2025041115513250700_zwaf151-B3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00787-021-01871-x","article-title":"The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)","volume":"32","author":"Coghill","year":"2023","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2025041115513250700_zwaf151-B4","doi-asserted-by":"crossref","first-page":"e12158","DOI":"10.1002\/jcv2.12158","article-title":"Attention-deficit\/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis","volume":"3","author":"Li","year":"2023","journal-title":"JCPP Adv"},{"key":"2025041115513250700_zwaf151-B5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/wps.21020","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study","volume":"21","author":"Li","year":"2022","journal-title":"World Psychiatry"},{"key":"2025041115513250700_zwaf151-B6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1037\/hea0001193","article-title":"Association between history of attention-deficit\/hyperactivity disorder diagnosis and cardiovascular disease in U.S. adults","volume":"41","author":"Xu","year":"2022","journal-title":"Health Psychol"},{"key":"2025041115513250700_zwaf151-B7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/brainsci9100256","article-title":"The association between ADHD and obesity: intriguing, progressively more investigated, but still puzzling","volume":"9","author":"Cortese","year":"2019","journal-title":"Brain Sci"},{"key":"2025041115513250700_zwaf151-B8","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1017\/S0033291720000665","article-title":"ADHD and depression: investigating a causal explanation","volume":"51","author":"Riglin","year":"2021","journal-title":"Psychol Med"},{"key":"2025041115513250700_zwaf151-B9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10567-010-0070-3","article-title":"Why does ADHD confer risk for cigarette smoking? A review of psychosocial mechanisms","volume":"13","author":"Glass","year":"2010","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2025041115513250700_zwaf151-B10","doi-asserted-by":"crossref","first-page":"105076","DOI":"10.1016\/j.neubiorev.2023.105076","article-title":"The association between type 2 diabetes and attention- deficit\/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study","volume":"147","author":"Garcia-Argibay","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"2025041115513250700_zwaf151-B11","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1038\/s41598-021-86003-w","article-title":"Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention","volume":"11","author":"Sia","year":"2021","journal-title":"Sci Rep"},{"key":"2025041115513250700_zwaf151-B12","doi-asserted-by":"crossref","first-page":"644189","DOI":"10.3389\/fcvm.2021.644189","article-title":"Type 2 diabetes and myocardial infarction: recent clinical evidence and perspective","volume":"8","author":"Cui","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2025041115513250700_zwaf151-B13","doi-asserted-by":"crossref","first-page":"e001286","DOI":"10.1136\/openhrt-2020-001286","article-title":"Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia","volume":"7","author":"Attar","year":"2020","journal-title":"Open Heart"},{"key":"2025041115513250700_zwaf151-B14","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/2047487319841475","article-title":"Persistent emotional distress after a first-time myocardial infarction and its association to late cardiovascular and non-cardiovascular mortality","volume":"26","author":"Liss\u00e5ker","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2025041115513250700_zwaf151-B15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2025041115513250700_zwaf151-B16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14779072.2023.2279608","article-title":"How can we improve the management of individuals with attention deficit hyperactivity disorders and co-occurring cardiometabolic disease?","volume":"21","author":"Larsson","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025041115513250700_zwaf151-B17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1186\/s12913-020-05643-2","article-title":"A qualitative study exploring the barriers and facilitators of implementing a cardiovascular disease risk reducing intervention for people with severe mental illness into primary care contexts across England: the \u2018PRIMROSE\u2019 trial","volume":"20","author":"Hassan","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2025041115513250700_zwaf151-B18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","article-title":"The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)","volume":"96","author":"Tomas","year":"2010","journal-title":"Heart"},{"key":"2025041115513250700_zwaf151-B19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jama.2024.0851","article-title":"ADHD pharmacotherapy and mortality in individuals with ADHD","volume":"331","author":"Li","year":"2024","journal-title":"JAMA"},{"key":"2025041115513250700_zwaf151-B20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/npy.13.59","article-title":"Changes in the definition of ADHD in DSM-5: subtle but important","volume":"3","author":"Epstein","year":"2013","journal-title":"Neuropsychiatry (London)"},{"key":"2025041115513250700_zwaf151-B21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"The Lancet"},{"key":"2025041115513250700_zwaf151-B22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/apt.12271","article-title":"The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease","volume":"37","author":"Emilsson","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2025041115513250700_zwaf151-B23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025041115513250700_zwaf151-B24","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehac798","article-title":"Long-term outcomes of perioperative myocardial infarction\/injury after non-cardiac surgery","volume":"44","author":"Puelacher","year":"2023","journal-title":"Eur Heart J"},{"key":"2025041115513250700_zwaf151-B25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"key":"2025041115513250700_zwaf151-B26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"2025041115513250700_zwaf151-B27","first-page":"1","article-title":"mice: Multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2025041115513250700_zwaf151-B28","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Jonathan","year":"2009","journal-title":"BMJ"},{"key":"2025041115513250700_zwaf151-B29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11634-022-00519-1","article-title":"Clustering with missing data: which equivalent for rubin\u2019s rules?","volume":"17","author":"Audigier","year":"2023","journal-title":"Adv Data Anal Classif"},{"key":"2025041115513250700_zwaf151-B30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.109.076935","article-title":"Treatment with antipsychotics and the risk of diabetes in clinical practice","volume":"197","author":"Andersen","year":"2010","journal-title":"British Journal of Psychiatry"},{"key":"2025041115513250700_zwaf151-B31","doi-asserted-by":"crossref","first-page":"22628","DOI":"10.1038\/s41598-021-01517-7","article-title":"Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD","volume":"11","author":"Garc\u00eda-Mar\u00edn","year":"2021","journal-title":"Sci Rep"},{"key":"2025041115513250700_zwaf151-B32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2215-0366(21)00171-1","article-title":"Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study","volume":"8","author":"Du Rietz","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2025041115513250700_zwaf151-B33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0038-1639501","article-title":"Anxiety-related bleeding and thrombosis","volume":"44","author":"Hoirisch-Clapauch","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"2025041115513250700_zwaf151-B34","doi-asserted-by":"crossref","first-page":"e209649","DOI":"10.1001\/jamanetworkopen.2020.9649","article-title":"Association of smoking cessation and survival among young adults with myocardial infarction in the partners YOUNG-MI registry","volume":"3","author":"Biery","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025041115513250700_zwaf151-B35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmacy10050106","article-title":"Medication adherence and compliance: recipe for improving patient outcomes","volume":"10","author":"Aremu","year":"2022","journal-title":"Pharmacy (Basel)"},{"key":"2025041115513250700_zwaf151-B36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/joim.12329","article-title":"Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study","volume":"277","author":"Bod\u00e9n","year":"2015","journal-title":"J Intern Med"},{"key":"2025041115513250700_zwaf151-B37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neubiorev.2020.07.042","article-title":"Prevalence of attention-deficit\/hyperactivity disorder in older adults: a systematic review and meta-analysis","volume":"118","author":"Dobrosavljevic","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"2025041115513250700_zwaf151-B38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14737175.2023.2250913","article-title":"The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults","volume":"23","author":"Dobrosavljevic","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"2025041115513250700_zwaf151-B39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/aje\/kwt312","article-title":"Comparison of random forest and parametric imputation models for imputing missing data using MICE: a CALIBER study","volume":"179","author":"Shah","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2025041115513250700_zwaf151-B40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.acvd.2022.05.012","article-title":"Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: rationale and design of the ADDICT-ICCU trial, from the emergency and acute cardiovascular care working group and the national college of cardiologists in training of the French society of cardiology","volume":"115","author":"Dillinger","year":"2022","journal-title":"Arch Cardiovasc Dis"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf151\/62916029\/zwaf151.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf151\/62916029\/zwaf151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:51:47Z","timestamp":1744372307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwaf151\/8111539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf151","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"article-number":"zwaf151"}}